How I manage anemia related to myelofibrosis and its treatment regimens

Myelofibrosis (MF) is a myeloproliferative neoplasm characterized by mutations (most frequently in JAK2, CALR, or MPL), burdensome symptoms, splenomegaly, cytopenia, and shortened life expectancy. In addition to other clinical manifestations, patients with MF often develop anemia, which can either b...

Descripción completa

Detalles Bibliográficos
Autor principal: Verstovsek, Srdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998582/
https://www.ncbi.nlm.nih.gov/pubmed/36786879
http://dx.doi.org/10.1007/s00277-023-05126-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998582/
https://www.ncbi.nlm.nih.gov/pubmed/36786879
http://dx.doi.org/10.1007/s00277-023-05126-4

Ejemplares similares